Home/All Molecules/Ranitidine

Ranitidine Range

Comprehensive Ranitidine portfolio for Franchise & Manufacturing.

Category
ranitidine
Total Formulations
12
Available Forms
Injection, Suspension, Syrup, Tablets

Expand Your Business with Our Multiple Divisions


Browse Ranitidine portfolio by Dosage Form


The Cafoli Advantage for PCD Franchise & Manufacturing

WHO-GMP Quality

Every Ranitidine batch undergoes rigorous in-house and third-party testing, strictly adhering to WHO-GMP standards for efficacy and safety.

Quality Policy

Monopoly & Branding

Secure exclusive PCD franchise rights for your territory and benefit from our range of premium, marketing-driven product packaging.

Market Strategy

Sales Support

Enhance your sales with Cafoli’s complete kit of marketing materials, including visual aids, MR bags, catch covers, and product cards.

Marketing Tools

Ranitidine PCD Pharma Franchise

Ranitidine PCD Pharma Franchise Company

Cafoli Lifecare is a WHO-GMP certified Ranitidine PCD pharma franchise company offering a portfolio of 12 Ranitidine formulations across tablets, syrup, suspension and injection. Every batch is manufactured at DCGI-approved facilities and supplied to franchise partners with district-level monopoly rights, ready-to-use promotional inputs and dependable stock availability.

What is Ranitidine?

Ranitidine is a histamine H2-receptor antagonist. It competitively blocks H2 receptors on gastric parietal cells, reducing basal and stimulated acid output and raising intragastric pH. The compound record can be reviewed on PubChem.

Therapeutic Applications

Duodenal and gastric ulcer, gastro-oesophageal reflux, dyspepsia, stress-ulcer prophylaxis, and pre-anaesthetic acid reduction. The injection is used in hospital and surgical settings where oral therapy is not feasible.

Prescribed by: General physicians, surgeons, gastroenterologists and anaesthetists prescribe Ranitidine; the injectable is largely an inpatient and peri-operative product.

Why Ranitidine is a High-Potential Molecule for Distributors

Ranitidine sits in a category that regulators worldwide have re-examined, so supply must come only from a certified manufacturer with strict batch-wise quality testing. That has actually narrowed the field of credible suppliers, and for a distributor working with a WHO-GMP certified partner it means less price-driven competition and a defensible position on quality. Where it remains in use, the injectable and syrup formats retain steady institutional and paediatric-adjacent demand that oral tablets alone do not cover.

Why Choose Cafoli Lifecare

Cafoli Lifecare offers its Ranitidine franchise partners genuine monopoly rights for their allotted district or territory, products manufactured in WHO-GMP certified, DCGI-approved units, and complete promotional support — visual aids, MR bags, sample packs, product cards and doctor gifting. With 1000+ channel partners across India, on-time dispatch and transparent net rates, we make it straightforward to build a profitable Ranitidine business in your region.

References

  1. PubChem – Ranitidine compound record, US National Library of Medicine
  2. PubMed – clinical literature on Ranitidine, NCBI

Aceclofenac in Modern Clinical Practice

Our formulations of Ranitidine find application in many critical therapeutic areas. Its therapeutic spectrum includes, but is not limited to:


FAQ about Ranitidine in PCD Franchise

Start Your Ranitidine Franchise with Cafoli Lifecare

Ready to take monopoly rights for Ranitidine in your district? Talk to our franchise team for net rates, packing details and the current availability list. Call 9518447302 or email info@cafoli.in.

Regulatory Compliance & Professional Verification

This catalog is a digital representation of the Cafoli Lifecare portfolio and is intended for use by authorized pharmaceutical distributors and PCD franchise partners.

  • No Consumer Sale: We do not entertain retail inquiries or direct sales to patients.
  • Information Accuracy: While we strive for accuracy, product availability, packaging, and regulatory status may change based on CDSCO guidelines and state-specific drug laws.
  • Medical Advice: Patients are strictly advised not to self-medicate or use this information for treatment. Always consult a qualified medical practitioner.
  • Licensing: All business associations are subject to the submission of valid GST and Drug License (DL) documentation.

Frequently Asked Questions (FAQs)

Cafoli Lifecare offers 12 Ranitidine formulations in tablets, syrup, suspension and injection. The current list with packing and net rates is shared with registered franchise enquiries.

Yes. Monopoly rights for the Ranitidine range are allotted district-wise on a first-come basis and are confirmed in your franchise agreement, so no other Cafoli partner sells the same brands in your territory.

General physicians, surgeons, gastroenterologists and anaesthetists prescribe Ranitidine; the injectable is largely an inpatient and peri-operative product.

Ranitidine is a prescription-only medicine and Cafoli supplies it strictly to partners holding a valid Drug License, from WHO-GMP certified, DCGI-approved units with batch-wise quality testing. Because the molecule has been subject to regulatory scrutiny internationally, sourcing from a certified manufacturer with documented quality checks is essential, and product availability is confirmed at the time of order.

You need a valid Drug License and a GST registration in your name. Once these are shared along with your territory preference, the Ranitidine franchise agreement and monopoly allotment can be processed.